RSV Prevention, Part I: Pediatric Monoclonal Antibodies

Avalere Essential Voice

English - September 28, 2022 19:16 - 8 minutes - 12 MB
Medicine Health & Fitness Science Life Sciences Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: NCDs, Part III: Agency Mandates, Decisions, Coverage, and Access

Next Episode: RSV Prevention, Part II: Pediatric Vaccines and Maternal immunization

Tune into the first episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss how innovative offerings in the pediatric RSV immunization market will fit within the continuum of care and how the RSV preventive market will grow in the upcoming years.